-
1
-
-
1442312192
-
An update on the pathogenesis and epidemiology of osteoarthritis
-
Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin. North. Am. 2004; 42:1-9.
-
(2004)
Radiol Clin. North. Am
, vol.42
, pp. 1-9
-
-
Felson, D.T.1
-
2
-
-
0033775218
-
Osteoarthriti s: New insights. Part 1: The disease and its risk factors
-
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fri es JF. Osteoarthriti s: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000; 133: 635-646.
-
(2000)
Ann Intern Med
, vol.133
, pp. 635-646
-
-
Felson, D.T.1
Lawrence, R.C.2
Dieppe, P.A.3
Hirsch, R.4
Helmick, C.G.5
Jordan, J.M.6
Kington, R.S.7
Lane, N.E.8
Nevitt, M.C.9
Zhang, Y.10
Sowers, M.11
McAlindon, T.12
Spector, T.D.13
Poole, A.R.14
Yanovski, S.Z.15
Ateshian, G.16
Sharma, L.17
Buckwalter, J.A.18
Brandt, K.D.19
Fries, J.F.20
more..
-
3
-
-
0034800418
-
Understanding NSAIDs: From aspirin to COX-2
-
Green GA: Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone 2001, 3:50-60.
-
(2001)
Clin Cornerstone
, vol.3
, pp. 50-60
-
-
Green, G.A.1
-
4
-
-
0028849234
-
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology
-
Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum. 1995; 38: 1541-1546.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 1541-1546
-
-
Hochberg, M.C.1
Altman, R.D.2
Brandt, K.D.3
Clark, B.M.4
Dieppe, P.A.5
Griffin, M.R.6
Moskowitz, R.W.7
Schnitzer, T.J.8
-
5
-
-
0033710649
-
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
-
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines
-
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000; 43: 1905-1915.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1905-1915
-
-
-
6
-
-
0033634938
-
EULAR recommendations for the management of osteoarthritis: Report of task force standing committee for International Clinical Studies including Therapeutic Trials (ESCISIT)
-
Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, Cluzeau F, Cooper C, Dieppe PA, Günther KP, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis PM, Leeb B, Lequesne M, Lohmander S, Mazieres B, Mola EM, Pavelka K, Serni U, Swoboda B, Verbruggen AA, Weseloh G, Zimmermann-Gorska I. EULAR recommendations for the management of osteoarthritis: report of task force standing committee for International Clinical Studies including Therapeutic Trials (ESCISIT). Ann Rheum. Dis. 2000; 59: 936-944.
-
(2000)
Ann Rheum. Dis
, vol.59
, pp. 936-944
-
-
Pendleton, A.1
Arden, N.2
Dougados, M.3
Doherty, M.4
Bannwarth, B.5
Bijlsma, J.W.6
Cluzeau, F.7
Cooper, C.8
Dieppe, P.A.9
Günther, K.P.10
Hauselmann, H.J.11
Herrero-Beaumont, G.12
Kaklamanis, P.M.13
Leeb, B.14
Lequesne, M.15
Lohmander, S.16
Mazieres, B.17
Mola, E.M.18
Pavelka, K.19
Serni, U.20
Swoboda, B.21
Verbruggen, A.A.22
Weseloh, G.23
Zimmermann-Gorska, I.24
more..
-
7
-
-
0032572548
-
Recent considerations in nonsteroidal anti-inflammatory drug gastropathy
-
Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am. J. Med. 1998; 105: 31S-38S.
-
(1998)
Am. J. Med
, vol.105
-
-
Singh, G.1
-
8
-
-
0032579890
-
Epidemiology of nonsteroidal anti-inflammatory drug associated gastrointestinal injury
-
Griffin MR. Epidemiology of nonsteroidal anti-inflammatory drug associated gastrointestinal injury. Am. J. Med. 1998; 104: 23S-29S.
-
(1998)
Am. J. Med
, vol.104
-
-
Griffin, M.R.1
-
9
-
-
0036440314
-
Double-edged sword of COX-2 selective NSAIDs
-
Wright JM. Double-edged sword of COX-2 selective NSAIDs. CMAJ 2002; 167: 1131-1137.
-
(2002)
CMAJ
, vol.167
, pp. 1131-1137
-
-
Wright, J.M.1
-
10
-
-
0022446751
-
Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent
-
Singh GB, Atal CK. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 1986; 18: 407-412.
-
(1986)
Agents Actions
, vol.18
, pp. 407-412
-
-
Singh, G.B.1
Atal, C.K.2
-
11
-
-
18744368220
-
Boswellia: An evidence-based systematic review by the natural standard research collaboration
-
Ethan B, Heather B, Theresa DH, Ivo F, Sadaf H, Jens H, David S, Catherine U. Boswellia: An evidence-based systematic review by the natural standard research collaboration. J Herbal Pharmacother. 2004; 4: 63-83.
-
(2004)
J Herbal Pharmacother
, vol.4
, pp. 63-83
-
-
Ethan, B.1
Heather, B.2
Theresa, D.H.3
Ivo, F.4
Sadaf, H.5
Jens, H.6
David, S.7
Catherine, U.8
-
12
-
-
0026624938
-
Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase
-
Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HPT. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol. Exp. Ther. 1992; 26: 1143-1146.
-
(1992)
J Pharmacol. Exp. Ther
, vol.26
, pp. 1143-1146
-
-
Safayhi, H.1
Mack, T.2
Sabieraj, J.3
Anazodo, M.I.4
Subramanian, L.R.5
Ammon, H.P.T.6
-
13
-
-
0030070162
-
Acetyl-11-keto-β-boswellic acid (AKBA): Structure requirements or binding and 5-lipoxygenase inhibitory activity
-
Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HPT, Safayhi H. Acetyl-11-keto-β-boswellic acid (AKBA): structure requirements or binding and 5-lipoxygenase inhibitory activity. Br. J Pharmacol. 1996; 117: 615-618.
-
(1996)
Br. J Pharmacol
, vol.117
, pp. 615-618
-
-
Sailer, E.R.1
Subramanian, L.R.2
Rall, B.3
Hoernlein, R.F.4
Ammon, H.P.T.5
Safayhi, H.6
-
14
-
-
20144389476
-
Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells
-
Roy S, Khanna S, Shah H, Rink C, Phillips C, Preuss H, Subbaraju GV, Trimurtulu G, Krishnaraju AV, Bagchi M, Bagchi D, Sen CK: Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. 2005; 24: 244-255.
-
(2005)
DNA Cell Biol
, vol.24
, pp. 244-255
-
-
Roy, S.1
Khanna, S.2
Shah, H.3
Rink, C.4
Phillips, C.5
Preuss, H.6
Subbaraju, G.V.7
Trimurtulu, G.8
Krishnaraju, A.V.9
Bagchi, M.10
Bagchi, D.11
Sen, C.K.12
-
15
-
-
33646698430
-
Regulation of vascular response to inflammation: Inducible Matrix Metalloprotenase-3 expression in Human Microvascular Endothelial Cells is sensitive to anti-inflammatory boswellia
-
Roy S, Khanna S, Krishnaraju AV, Subbaraju GV, Yasmin T, Bagchi D and Sen CK. Regulation of vascular response to inflammation: Inducible Matrix Metalloprotenase-3 expression in Human Microvascular Endothelial Cells is sensitive to anti-inflammatory boswellia. Antioxidant and Redox Signaling. 2006; 8: 653-660.
-
(2006)
Antioxidant and Redox Signaling
, vol.8
, pp. 653-660
-
-
Roy, S.1
Khanna, S.2
Krishnaraju, A.V.3
Subbaraju, G.V.4
Yasmin, T.5
Bagchi, D.6
Sen, C.K.7
-
16
-
-
68849118134
-
Inhibition of TNFα Production and Blocking of Mitogen-Activated Protein Kinase/NFkB Activation In Lipopolysaccharide-Induced THP-1 Human Monocytes By 3-O-Acetyl-11-Keto-β-Boswellic Acid
-
Sengupta K, Golakoti T, Marasetti A K, Tummala T, Ravada S R, Krishnaraju AV, Raychaudhuri SP. Inhibition of TNFα Production and Blocking of Mitogen-Activated Protein Kinase/NFkB Activation In Lipopolysaccharide-Induced THP-1 Human Monocytes By 3-O-Acetyl-11-Keto-β-Boswellic Acid. J Food Lipids 2009; 16: 325-344.
-
(2009)
J Food Lipids
, vol.16
, pp. 325-344
-
-
Sengupta, K.1
Golakoti, T.2
Marasetti, A.K.3
Tummala, T.4
Ravada, S.R.5
Krishnaraju, A.V.6
Raychaudhuri, S.P.7
-
18
-
-
85088340719
-
®; Study No.4477/05
-
Advinus Therapeutics Private Limited, Post Box No.5813, Plot Nos 21 & 22, Peenya Industrial Area, Phase II, Bangalore, India 560 058. Bangalore, India: Advinus Therapeutics Private Limited
-
®; Study No.4477/05, Toxicology Department, Advinus Therapeutics Private Limited, Post Box No.5813, Plot Nos 21 & 22, Peenya Industrial Area, Phase II, Bangalore, India 560 058. Bangalore, India: Advinus Therapeutics Private Limited. 2006.
-
(2006)
Toxicology Department
-
-
Indrani, B.K.1
-
19
-
-
85088338443
-
®; Study number MN00075
-
101, Lane 169, Kangning St, Xizhi City, Taipei County 221, Taiwan. Taiwan: Development Center for Biotechnology
-
®; Study number MN00075, Center of Toxicology and Preclinical Sciences, Development Center for Biotechnology, 101, Lane 169, Kangning St, Xizhi City, Taipei County 221, Taiwan. Taiwan: Development Center for Biotechnology. 2007.
-
(2007)
Center of Toxicology and Preclinical Sciences, Development Center For Biotechnology
-
-
Chang, J.T.1
-
20
-
-
78649657894
-
Chromosomal abberation test; Study number CA00094
-
101, Lane 169, Kangning St, Xizhi City, Taipei County 221, Taiwan. Taiwan: Development Center for Biotechnology
-
Jung-Ti, Chang. Chromosomal abberation test; Study number CA00094, Center of Toxicology and Preclinical Sciences, Development Center for Biotechnology, 101, Lane 169, Kangning St, Xizhi City, Taipei County 221, Taiwan. Taiwan: Development Center for Biotechnology. 2007.
-
(2007)
Center of Toxicology and Preclinical Sciences, Development Center For Biotechnology
-
-
Jung-Ti, C.1
-
21
-
-
84886552475
-
-
Bagchi D, Lau FC, Bagchi M, eds., MA: Wiley-Blackwell
-
Trimurtulu G, Sen CK, Krishnaraju AV, Sengupta K. In: Bagchi D, Lau FC, Bagchi M, eds. Genomic basis of anti-inflammatory properties of Boswellia extract: Genomics, Proteomics and Metabolomics in Nutrational and Functional Foods. MA: Wiley-Blackwell. 2010: 155-174.
-
(2010)
Genomic Basis of Anti-inflammatory Properties of Boswellia Extract: Genomics, Proteomics and Metabolomics In Nutrational and Functional Foods
, pp. 155-174
-
-
Trimurtulu, G.1
Sen, C.K.2
Krishnaraju, A.V.3
Sengupta, K.4
-
22
-
-
48849107660
-
® for treatment of osteoarthritis of the knee
-
® for treatment of osteoarthritis of the knee. Arthritis Res. Ther. 2008; 10(4): R85
-
(2008)
Arthritis Res. Ther
, vol.10
, Issue.4
-
-
Sengupta, K.1
Alluri, K.V.2
Satish, A.R.3
Mishra, S.4
Golakoti, T.5
Sarma, K.V.6
Dey, D.7
Raychaudhuri, S.P.8
-
24
-
-
33847119383
-
Use of complementary and alternative medicine in Germany- a survey of subjects with inflammatory bowel disease
-
Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany- a survey of subjects with inflammatory bowel disease. BMC Comp. Altern. Med. 2006; 6: 19.
-
(2006)
BMC Comp. Altern. Med
, vol.6
, pp. 19
-
-
Joos, S.1
Rosemann, T.2
Szecsenyi, J.3
Hahn, E.G.4
Willich, S.N.5
Brinkhaus, B.6
-
25
-
-
33646873067
-
Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis
-
Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, Muller S, Senninger N, Russell J, Jauch J, Bergmann J, Granger DN, Krieglstein CF. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am. J Physiol. Gastrointest. Liver Physiol. 2006; 290: G1131-G1137.
-
(2006)
Am. J Physiol. Gastrointest. Liver Physiol
, vol.290
-
-
Anthoni, C.1
Laukoetter, M.G.2
Rijcken, E.3
Vowinkel, T.4
Mennigen, R.5
Muller, S.6
Senninger, N.7
Russell, J.8
Jauch, J.9
Bergmann, J.10
Granger, D.N.11
Krieglstein, C.F.12
-
26
-
-
0034941316
-
Effects of gum resin of Boswellia serrata in subjects with chronic colitis
-
Gupta I, Parihar A, Malhotra P, Gupta S, Ludtke R, Safayhi H, Ammon HP. Effects of gum resin of Boswellia serrata in subjects with chronic colitis. Planta Med. 2001; 67: 391-395.
-
(2001)
Planta Med
, vol.67
, pp. 391-395
-
-
Gupta, I.1
Parihar, A.2
Malhotra, P.3
Gupta, S.4
Ludtke, R.5
Safayhi, H.6
Ammon, H.P.7
-
27
-
-
0037282674
-
Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: A randomized double blind placebo controlled trial
-
Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: a randomized double blind placebo controlled trial. Phytomedicine 2003; 10: 3-7.
-
(2003)
Phytomedicine
, vol.10
, pp. 3-7
-
-
Kimmatkar, N.1
Thawani, V.2
Hingorani, L.3
Khiyani, R.4
-
28
-
-
0024268463
-
Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to anti-rheumatic drug therapy in subjects with osteoarthritis of the hip or knee
-
Bellamy N, Buchnan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to anti-rheumatic drug therapy in subjects with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15: 1833-1840.
-
(1988)
J Rheumatol
, vol.15
, pp. 1833-1840
-
-
Bellamy, N.1
Buchnan, W.W.2
Goldsmith, C.H.3
Campbell, J.4
Stitt, L.W.5
-
29
-
-
0023477362
-
Indexes of severity for osteoarthritis of the hip and knee validation-value in comparison with other assessment tests
-
Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee validation-value in comparison with other assessment tests. Scand J Rheumatology 1987; 65: 85-89.
-
(1987)
Scand J Rheumatology
, vol.65
, pp. 85-89
-
-
Lequesne, M.G.1
Mery, C.2
Samson, M.3
Gerard, P.4
-
30
-
-
0021795389
-
Pain measurement: An overview
-
Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. Pain measurement: an overview. Pain 1985; 22: 1-31.
-
(1985)
Pain
, vol.22
, pp. 1-31
-
-
Chapman, C.R.1
Casey, K.L.2
Dubner, R.3
Foley, K.M.4
Gracely, R.H.5
Reading, A.E.6
-
31
-
-
13544256541
-
The effectiveness of hylan G-F 20 in subjects with knee osteoarthritis: An application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI
-
Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, Torrance GW, Tugwell P, Polisson R. The effectiveness of hylan G-F 20 in subjects with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI. Osteoarthritis Cartilage 2005; 13: 104-110.
-
(2005)
Osteoarthritis Cartilage
, vol.13
, pp. 104-110
-
-
Bellamy, N.1
Bell, M.J.2
Goldsmith, C.H.3
Pericak, D.4
Walker, V.5
Raynauld, J.P.6
Torrance, G.W.7
Tugwell, P.8
Polisson, R.9
-
32
-
-
0034922054
-
Effect of nerve growth factor on endothelial cell biology: Proliferation and adherence molecule expression on human dermal microvascular endothelial cells
-
Raychaudhuri SK, Raychaudhuri SP, Weltman H, Farber EM. Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res. 2001; 293(6): 291-295.
-
(2001)
Arch Dermatol Res
, vol.293
, Issue.6
, pp. 291-295
-
-
Raychaudhuri, S.K.1
Raychaudhuri, S.P.2
Weltman, H.3
Farber, E.M.4
-
33
-
-
0034717664
-
A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in subjects with osteoarthritis
-
Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in subjects with osteoarthritis. Arch. Intern. Med. 2000; 160: 1781-1787.
-
(2000)
Arch. Intern. Med
, vol.160
, pp. 1781-1787
-
-
Day, R.1
Morrison, B.2
Luza, A.3
Castaneda, O.4
Strusberg, A.5
Nahir, M.6
Helgetveit, K.B.7
Kress, B.8
Daniels, B.9
Bolognese, J.10
Krupa, D.11
Seidenberg, B.12
Ehrich, E.13
-
34
-
-
0036733531
-
Results of a randomized, dose-ranging trial of etoricoxib in subjects with osteoarthritis
-
Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ. Results of a randomized, dose-ranging trial of etoricoxib in subjects with osteoarthritis. Rheumatology (Oxford). 2002; 41:1052-1061.
-
(2002)
Rheumatology (Oxford)
, vol.41
, pp. 1052-1061
-
-
Gottesdiener, K.1
Schnitzer, T.2
Fisher, C.3
Bockow, B.4
Markenson, J.5
Ko, A.6
Detora, L.7
Curtis, S.8
Geissler, L.9
Gertz, B.J.10
-
35
-
-
33847420941
-
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies
-
Bingham CO, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford).2007; 46: 496-507.
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 496-507
-
-
Bingham, C.O.1
Sebba, A.I.2
Rubin, B.R.3
Ruoff, G.E.4
Kremer, J.5
Bird, S.6
Smugar, S.S.7
Fitzgerald, B.J.8
O'Brien, K.9
Tershakovec, A.M.10
-
36
-
-
34347242059
-
Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomized studies of osteoarthritis subjects
-
Reginster JY, Malmstrom K, Mehta A, Bergman G, Ko AT, Curtis SP, Reicin AS: Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomized studies of osteoarthritis subjects. Ann. Rheum. Dis. 2007; 66: 945-951.
-
(2007)
Ann. Rheum. Dis
, vol.66
, pp. 945-951
-
-
Reginster, J.Y.1
Malmstrom, K.2
Mehta, A.3
Bergman, G.4
Ko, A.T.5
Curtis, S.P.6
Reicin, A.S.7
-
37
-
-
78649642770
-
-
[Internet] Power analysis for ANOVA designs
-
[Internet] Power analysis for ANOVA designs. http://www.math.yorku.cal/SCS/Online/power/
-
-
-
-
38
-
-
0020682296
-
Collagenase and collagenolytic activity in human osteoarthritic cartilage
-
Pelletier JP, Martel-Pelletier J, Howell DS, Ghandur-Mnaymneh L, Enis JE, Woessner JF Jr: Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum. 1983; 26: 63-68.
-
(1983)
Arthritis Rheum
, vol.26
, pp. 63-68
-
-
Pelletier, J.P.1
Martel-Pelletier, J.2
Howell, D.S.3
Ghandur-Mnaymneh, L.4
Enis, J.E.5
Woessner Jr., J.F.6
-
40
-
-
0034121686
-
Molecular basis and clinical use of biochemical markers of bone, cartilage and synovium in joint diseases
-
Garnero P, Rousseau J, Delmas PD. Molecular basis and clinical use of biochemical markers of bone, cartilage and synovium in joint diseases. Arthritis Rheum. 2000; 43: 953-968.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 953-968
-
-
Garnero, P.1
Rousseau, J.2
Delmas, P.D.3
-
41
-
-
33344467770
-
Osteoarthritis of the knee
-
Felson DT. Osteoarthritis of the knee. N Engl J Med. 2006; 354: 841-848.
-
(2006)
N Engl J Med
, vol.354
, pp. 841-848
-
-
Felson, D.T.1
-
42
-
-
0028242319
-
The importance of placebo effects in pain treatment and research
-
Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994; 271: 1609-1614.
-
(1994)
JAMA
, vol.271
, pp. 1609-1614
-
-
Turner, J.A.1
Deyo, R.A.2
Loeser, J.D.3
Von Korff, M.4
Fordyce, W.E.5
-
43
-
-
24944482692
-
The therapeutic effect of clinical trials: Understanding placebo response rates in clinical trials: A secondary analysis
-
Walach H, Sadaghiani C, Dehm C, Bierman D. The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials: a secondary analysis. BMC Med Res Methodol. 2005; 5: 26-37.
-
(2005)
BMC Med Res Methodol
, vol.5
, pp. 26-37
-
-
Walach, H.1
Sadaghiani, C.2
Dehm, C.3
Bierman, D.4
-
45
-
-
0036247674
-
Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation
-
Little CB, Hughes CE, Curtis CL, Janusz MJ, Bohne R, Wang-Weigand S, Taiwo YO, Mitchell PG, Otterness IG, Flannery CR, Caterson B. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol. 2002; 21: 271-288.
-
(2002)
Matrix Biol
, vol.21
, pp. 271-288
-
-
Little, C.B.1
Hughes, C.E.2
Curtis, C.L.3
Janusz, M.J.4
Bohne, R.5
Wang-Weigand, S.6
Taiwo, Y.O.7
Mitchell, P.G.8
Otterness, I.G.9
Flannery, C.R.10
Caterson, B.11
-
46
-
-
0025332578
-
Effects of tumour necrosis factor-alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes
-
Campbell, IK, Piccolo, DS, Roberts, MJ, et al. Effects of tumour necrosis factor-alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum. 1990; 33: 542.
-
(1990)
Arthritis Rheum
, vol.33
, pp. 542
-
-
Campbell, I.K.1
Piccolo, D.S.2
Roberts, M.J.3
-
47
-
-
12344252610
-
Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage
-
Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005; 52(1): 128-135.
-
(2005)
Arthritis Rheum
, vol.52
, Issue.1
, pp. 128-135
-
-
Kobayashi, M.1
Squires, G.R.2
Mousa, A.3
Tanzer, M.4
Zukor, D.J.5
Antoniou, J.6
Feige, U.7
Poole, A.R.8
-
48
-
-
23944456615
-
Synovial tissue inflammation in early and late osteoarthritis
-
Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005; 64(9): 1263-1267.
-
(2005)
Ann Rheum Dis
, vol.64
, Issue.9
, pp. 1263-1267
-
-
Benito, M.J.1
Veale, D.J.2
Fitzgerald, O.3
van den Berg, W.B.4
Bresnihan, B.5
|